Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expand Energy Corporation Common Stock (EXE) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance

Expand Energy Corporation Common StockTrade
NeoGenomics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Expand Energy Corporation Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Expand Energy Corporation Common Stock trades at $91.6 (market cap $21.38B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: Expand Energy Corporation Common Stock is far larger — about 10× NeoGenomics Inc. Common Stock's market cap, and Expand Energy Corporation Common Stock pays a 2.49% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expand Energy Corporation Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.

EXENEO
Market Cap
$21.38B$2.14B
Volume
3,544,5702,228,400
Sector
EnergyHealth
52-Week High
$122.89$19.91
52-Week Low
$84.09$7.19
Typical Hold Time
0 Days0 Days
Enterprise Value
$24.45B$2.44B
Dividend Yield
2.49%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXE
100% Buy0% Sell
Avg holding period · 0 Days
NEO
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Expand Energy Corporation Common Stock

Expand Energy Corporation is a US natural gas producer formed from the 2024 merger of Chesapeake Energy and Southwestern Energy, developing gas assets concentrated in the Appalachia and Haynesville basins.

Read more on EXE →

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →